Curocell (XKRX:372320) EBITDA Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Curocell's EBITDA for the six months ended in Jun. 2023 was ₩-10,196.74 Mil. Curocell's Revenue for the six months ended in Jun. 2023 was ₩0.00 Mil. Therefore, Curocell's EBITDA margin for the quarter that ended in Jun. 2023 was 0.00%.

Curocell EBITDA Margin % Historical Data

The historical data trend for Curocell's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell EBITDA Margin % Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-3,644,345.00

-17,646.93

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	-	-	-	-

Competitive Comparison of Curocell's EBITDA Margin %

For the Biotechnology subindustry, Curocell's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Curocell's EBITDA Margin % falls into.

Curocell EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Curocell's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-22526.709	/	0
	=	%

Curocell's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-10196.741	/	0
	=	%

Curocell (XKRX:372320) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Curocell EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Curocell's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines